BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35137142)

  • 1. Performance of DHEAS as a Screening Test for Autonomous Cortisol Secretion in Adrenal Incidentalomas: A Prospective Study.
    Liu MS; Lou Y; Chen H; Wang YJ; Zhang ZW; Li P; Zhu DL
    J Clin Endocrinol Metab; 2022 Apr; 107(5):e1789-e1796. PubMed ID: 35137142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the 1mg-dexamethasone suppression test a precise marker of glucocorticoid excess and cardiometabolic risk in patients with adrenal incidentalomas?
    Araujo-Castro M; Hanzu FA; Pascual-Corrales E; García Cano AM; Marchan M; Escobar-Morreale HF; Valderrabano P; Casals G
    Endocrine; 2023 Oct; 82(1):161-170. PubMed ID: 37351760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low DHEAS: A Sensitive and Specific Test for the Detection of Subclinical Hypercortisolism in Adrenal Incidentalomas.
    Dennedy MC; Annamalai AK; Prankerd-Smith O; Freeman N; Vengopal K; Graggaber J; Koulouri O; Powlson AS; Shaw A; Halsall DJ; Gurnell M
    J Clin Endocrinol Metab; 2017 Mar; 102(3):786-792. PubMed ID: 27797672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of the different hormonal tests used for the diagnosis of autonomous cortisol secretion.
    Araujo-Castro M; García Cano A; Jiménez Mendiguchía L; Escobar-Morreale HF; Valderrábano P
    Sci Rep; 2021 Oct; 11(1):20539. PubMed ID: 34654835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of the dexamethasone suppression test for the prediction of autonomous cortisol secretion-related comorbidities in adrenal incidentalomas.
    Araujo-Castro M; Parra Ramírez P; Robles Lázaro C; García Centeno R; Gracia Gimeno P; Fernández-Ladreda MT; Sampedro Núñez MA; Marazuela M; Escobar-Morreale HF; Valderrabano P
    Hormones (Athens); 2021 Dec; 20(4):735-744. PubMed ID: 34273083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic testing of autonomous cortisol secretion in adrenal incidentalomas.
    Ueland GÅ; Grinde T; Methlie P; Kelp O; Løvås K; Husebye ES
    Endocr Connect; 2020 Oct; 9(10):963-970. PubMed ID: 33032259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The value of serum dehydroepiandrosterone sulfate in differential diagnosis of Cushing's syndrome].
    Liu MS; Zhang WJ; Zhu KY; Chen H; Feng WH; Zhu DL; Li P
    Zhonghua Yi Xue Za Zhi; 2020 Sep; 100(36):2822-2827. PubMed ID: 32988141
    [No Abstract]   [Full Text] [Related]  

  • 8. Predictive model for autonomous cortisol secretion development in non-functioning adrenal incidentalomas.
    Araujo-Castro M; García Cano AM; Escobar-Morreale HF; Valderrabano P
    Hormones (Athens); 2023 Mar; 22(1):51-59. PubMed ID: 36279032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated post-dexamethasone suppression cortisol concentrations correlate with hormonal alterations of the hypothalamo-pituitary adrenal axis in patients with adrenal incidentalomas.
    Tsagarakis S; Roboti C; Kokkoris P; Vasiliou V; Alevizaki C; Thalassinos N
    Clin Endocrinol (Oxf); 1998 Aug; 49(2):165-71. PubMed ID: 9828902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiometabolic profile of non-functioning and autonomous cortisol-secreting adrenal incidentalomas. Is the cardiometabolic risk similar or are there differences?
    Araujo-Castro M; Robles Lázaro C; Parra Ramírez P; Cuesta Hernández M; Sampedro Núñez MA; Marazuela M
    Endocrine; 2019 Dec; 66(3):650-659. PubMed ID: 31473918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACTH following overnight dexamethasone suppression can be used in the verification of autonomous cortisol secretion in patients with adrenal incidentalomas.
    Puvaneswaralingam S; Kjellbom A; Lindgren O; Löndahl M; Olsen H
    Clin Endocrinol (Oxf); 2021 Feb; 94(2):168-175. PubMed ID: 33108675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features, risk of mass enlargement, and development of endocrine hyperfunction in patients with adrenal incidentalomas: a long-term follow-up study.
    Falcetta P; Orsolini F; Benelli E; Agretti P; Vitti P; Di Cosmo C; Tonacchera M
    Endocrine; 2021 Jan; 71(1):178-188. PubMed ID: 32915435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Steroid Profile of Adrenal Incidentalomas: Subtyping Subjects With High Cardiovascular Risk.
    Di Dalmazi G; Fanelli F; Zavatta G; Ricci Bitti S; Mezzullo M; Repaci A; Pelusi C; Gambineri A; Altieri P; Mosconi C; Balacchi C; Golfieri R; Cosentino ER; Borghi C; Vicennati V; Pasquali R; Pagotto U
    J Clin Endocrinol Metab; 2019 Nov; 104(11):5519-5528. PubMed ID: 31381072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maximum adenoma diameter, regardless of uni- or bilaterality, is a risk factor for autonomous cortisol secretion in adrenal incidentalomas.
    Araujo-Castro M; Robles Lázaro C; Parra Ramírez P; García Centeno R; Gracia Gimeno P; Fernández-Ladreda MT; Sampedro Núñez MA; Marazuela M; Escobar-Morreale HF; Valderrabano P
    J Endocrinol Invest; 2021 Nov; 44(11):2349-2357. PubMed ID: 33683661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenal incidentaloma: an overview of hormonal data from the National Italian Study Group.
    Mantero F; Masini AM; Opocher G; Giovagnetti M; Arnaldi G
    Horm Res; 1997; 47(4-6):284-9. PubMed ID: 9167966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical course of patients with adrenal incidentalomas and cortisol autonomy: a German retrospective single center cohort study.
    Remde H; Kranz S; Morell SM; Altieri B; Kroiss M; Detomas M; Fassnacht M; Deutschbein T
    Front Endocrinol (Lausanne); 2023; 14():1123132. PubMed ID: 37223045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired Cognitive Function in Patients With Autonomous Cortisol Secretion in Adrenal Incidentalomas.
    Liu MS; Tian ZY; Zhang Z; Yang F; Lou Y; Wang YJ; Zeng YJ; Zhang ZW; Zhu DL; Li P
    J Clin Endocrinol Metab; 2023 Feb; 108(3):633-641. PubMed ID: 36263685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and incidence of type 2 diabetes mellitus in patients with adrenal incidentalomas: a study of 709 cases.
    Brox-Torrecilla N; García Cano AM; Valderrábano P; Quintero Tobar A; Escobar-Morreale HF; Araujo-Castro M
    Endocrine; 2023 Sep; 81(3):484-491. PubMed ID: 37212980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between contralateral adrenal and hypothalamus-pituitary-adrenal axis in benign adrenocortical tumors.
    Zhu H; Wu L; Su T; Jiang L; Zhou W; Jiang Y; Zhang C; Zhong X; Wang W
    Front Endocrinol (Lausanne); 2023; 14():1199875. PubMed ID: 37560307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressed ACTH Is Frequently Unrelated to Autonomous Cortisol Secretion in Patients With Adrenal Incidentalomas.
    Olsen H; Kjellbom A; Löndahl M; Lindgren O
    J Clin Endocrinol Metab; 2019 Feb; 104(2):506-512. PubMed ID: 30265354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.